Sujal M. Patel - 09 May 2022 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
CEO, President, and Secretary, Director, 10%+ Owner
Signature
/s/ Matthew B. Murphy, as Attorney-in-Fact
Issuer symbol
NAUT
Transactions as of
09 May 2022
Transactions value $
$198,000
Form type
4
Filing time
10 May 2022, 20:28:04 UTC
Previous filing
04 Mar 2022
Next filing
08 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAUT Common Stock Purchase $198K +50K +0.5% $3.96 9.96M 09 May 2022 Direct F1
holding NAUT Common Stock 5.28M 09 May 2022 By PFV I, LLC F2
holding NAUT Common Stock 1.81M 09 May 2022 By Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 50,000 shares purchased in the price range of $3.8299 to $4.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 Shares held by PFV I, LLC. The reporting person is the manager of PFV I, LLC.
F3 Shares held by Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 (the "Patel Trust"). The reporting person and the reporting person's spouse are the trustees of the Patel Trust.